compounded tirzepatide vs compounded semaglutide Semaglutide vs Tirzepatide: Which Leads to More Weight Loss? tirzepatide vs compounded semaglutide Comparing

Key takeaways Regain is common after stopping

View the full release here: Following GLP-1 deprescription, weight did not significantly increase at 6 or 12 months post deprescription, compared to many well-known drug trials (in red) where patients regain up to 2/3rds of weight loss after discontinuing the drug

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

It targets both GLP-1 and GIP (gastric inhibitory polypeptide) receptors to trigger enhanced metabolic effects

Escalation: Step the dose up every few weeks e.g

At 5 mg/mL, a half-unit increment changes your dose by 0.025 mg